Patent · US Active

Compounds for preparing immunological adjuvant

US8198474B2 · kind B2 · utility

3Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 2010
Grant dateJun 12, 2012
Priority date
Expiry dateSep 16, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides methods for preparing TLR-4 receptor agonist E6020:and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates useful for implementing the inventive methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.